Export this Abstract | Print this Abstract | Add to my preferred Abstracts list | My preferred Abstracts list (0) | Back to Search
A real world experience of empagliflozin in patients with type 2 diabetes: in a medical center in southern of taiwan
- At: 2017 FIP Congress in Seoul (South Korea)
- Type: Poster
- By: CHEN, Jungfang (Chi Mei medical center, Department of Pharmacy, Tainan City, China Taiwan)
- Co-author(s): Jungfang Chen
BackgroundWe aimed to investigate the efficacy of empagliflozin, in patients with type 2 diabetes who past treatment failure.
PurposeTo determine whether treatment with empagliflozin result in glycemic control and weight loss in real world practice. We presented our experience of empagliflozin in treating of overweight and obese type 2 diabetes.. The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress.
Last update 4 October 2019